Specifically in TNBC, inhibition of CDK9 has been linked to decreased cyclin B1 and MYC, and treatment with dinaciclib resulted in G2/M phase arrest and cancer cell apoptosis [28]. This evidence concerns the gene CDK9 and cancer.